# Treatment of biliary tract cancer - essentials for clinical practice

## TL;DR

This paper reviews current treatment strategies for biliary tract cancer, focusing on improving outcomes through tailored therapies and immunotherapy.

## Contribution

The paper offers an updated clinical overview of treatment options for biliary tract cancer, emphasizing personalized and combined therapeutic approaches.

## Key findings

- Early-stage biliary tract cancer patients benefit from postoperative therapy to reduce recurrence.
- Advanced or metastatic cases are best treated with systemic therapy combined with immunotherapy.
- Molecular profiling enables personalized treatment based on targetable alterations in some patients.

## Abstract

Biliary tract tumours represent a serious medical problem due to their high mortality rate. In early stages, patients are indicated for postoperative therapy after potentially curative surgery in order to reduce the risk of recurrence and prolong survival. Most patients with bile duct tumours are diagnosed at a locoregionally advanced and/or metastatic stage. The standard treatment for these patients is systemic therapy, now in combination with immunotherapy. Deepening knowledge of the molecular biology of this disease allows for the selection of treatment tailored to the individual patient based on the presence of specific targetable alterations in some patients. The article provides an overview of current treatment options for this disease across all stages.